Plant ID: NPO27239
Plant Latin Name: Maclura tinctoria
Taxonomy Genus: Maclura
Taxonomy Family: Moraceae
NCBI TaxonomyDB:
681456
Plant-of-the-World-Online:
1151750-2
Brazil; Jamaica; Belize; Honduras; Peru; Cuba; El Salvador; Venezuela; Mexico; Costa Rica; Trinidad and Tobago; Guatemala; Netherlands; China; Colombia; Paraguay; Dominican Republic; Bolivia; Nicaragua; Haiti
TSHR; | |
RECQL; TDP1; BLM; HSD17B1; HSD17B10; ALOX15; | |
MAPK1; PIM1; CSNK2A1; | |
CA2; CA1; CA12; CA9; CA5A; CA3; CA14; CA7; CA4; CA6; | |
ESR1; ESR2; | |
ELANE; | |
HIF1A; | |
LMNA; MAPT; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | P14061 | CHEMBL3181 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
Serine protease | ELANE | Leukocyte elastase | P08246 | CHEMBL248 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.923E-09 | 4.188E-06 | BLM, CA1, CA12, CA2, CA3, CA4, CA5A, CA6, CA7, CA9, ESR1, ESR2 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 8.862E-09 | 1.608E-05 | CYP19A1, CYP1B1, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 7.461E-08 | 1.083E-04 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.824E-07 | 2.336E-04 | ALOX15, CYP19A1, CYP1B1, CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 2.433E-07 | 2.944E-04 | CYP19A1, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 4.457E-07 | 4.412E-04 | CYP1B1, CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 8.154E-07 | 7.398E-04 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 6.667E-26 | 1.452E-21 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA6, CA7, CA9 |
MF | GO:0005488; binding | GO:0020037; heme binding | 1.748E-06 | 1.464E-03 | CYP19A1, CYP1B1, CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 2.493E-06 | 1.969E-03 | ESR1, ESR2 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 4.881E-06 | 3.322E-03 | CYP1B1, CYP2C19, CYP2C9 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 6.486E-06 | 4.280E-03 | CYP19A1, CYP1B1, CYP3A4 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 7.471E-06 | 4.648E-03 | CA2, CA7 |
MF | GO:0005488; binding | GO:0005496; steroid binding | 1.051E-05 | 6.073E-03 | CYP3A4, ESR1, ESR2, HSD17B1 |
BP | GO:0008152; metabolic process | GO:0008209; androgen metabolic process | 1.193E-05 | 6.496E-03 | CYP19A1, CYP3A4, ESR1 |
BP | GO:0009987; cellular process | GO:0033554; cellular response to stress | 1.422E-05 | 7.066E-03 | ALOX15, BLM, CA2, CA9, CYP1B1, HIF1A, LMNA, MAPK1, MAPT, RECQL, TDP1 |
MF | GO:0005488; binding | GO:0034056; estrogen response element binding | 1.493E-05 | 7.066E-03 | ESR1, ESR2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 1.493E-05 | 7.066E-03 | CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0051879; Hsp90 protein binding | 1.799E-05 | 8.160E-03 | CSNK2A1, HIF1A, MAPT |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 5.353E-20 | 5.828E-16 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.793E-18 | 9.760E-15 | CA1, CA12, CA2, CA3, CA4, CA5A, CA6, CA7, CA9 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 1.673E-04 | 4.496E-02 | HIF1A, MAPK1, MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 3.043E-25 | 3.774E-23 | CA12, CA1, CA3, CA2, CA5A, CA4, CA7, CA6, CA9, CA14 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.091E-07 | 6.767E-06 | CYP2C9, ALOX15, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.890E-06 | 7.810E-05 | HSD17B1, CYP1B1, CYP3A4, CYP19A1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 7.590E-06 | 2.353E-04 | CYP2C9, CYP1B1, CYP3A4, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 2.609E-05 | 6.471E-04 | CYP2C9, ALOX15, MAPK1, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 6.290E-05 | 1.300E-03 | HSD17B1, CYP1B1, CYP19A1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.199E-04 | 2.123E-03 | CYP2C9, ALOX15, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 1.870E-04 | 2.416E-03 | MAPK1, ESR1, ESR2 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.648E-04 | 2.416E-03 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.949E-04 | 2.416E-03 | CYP2C9, CYP1B1, CYP3A4 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 4.782E-04 | 5.390E-03 | MAPK1, ESR1, ESR2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 7.977E-04 | 7.609E-03 | MAPK1, ESR1, HIF1A |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 5.764E-04 | 5.957E-03 | CA2, CA4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA4; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |